Clinical Trial

A Study to Evaluate the Bioequivalence of DA-5230 Compared to DA-5230-R

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated April 7, 2026 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
A study to evaluate the bioequivalence of DA-5230 compared to DA-5230-R
Trial Details
NCT Number NCT07513649
Lead Sponsor Dong-A ST Co., Ltd.
Conditions Healthy Adult Participants
Enrollment 60 participants
Start Date 2026-04
Primary Completion 2026-05 (estimated)
Study Completion 2026-05 (estimated)
Updated on ClinicalTrials.gov 2026-04-07